Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
19.55
+0.21 (1.09%)
At close: Oct 15, 2026, 4:00 PM EDT
19.27
-0.28 (-1.43%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Braveheart Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +130.18% | Oct 1, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $48 | Buy | Maintains | $48 | +145.52% | Sep 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $40 | Buy | Initiates | $40 | +104.60% | Aug 31, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 31, 2026 |
| Jefferies No rating | Jefferies | Buy Initiates $48 | Buy | Initiates | $48 | +145.52% | Aug 31, 2026 |